Kinetic, Spectroscopic, and X-ray Crystallographic Characterization of the Functional E151H Aminopeptidase from \u3cem\u3eAeromonas proteolytica\u3c/em\u3e by Bzymek, Krzysztof P. et al.
Marquette University 
e-Publications@Marquette 
Physics Faculty Research and Publications Physics, Department of 
9-2005 
Kinetic, Spectroscopic, and X-ray Crystallographic 
Characterization of the Functional E151H Aminopeptidase from 
Aeromonas proteolytica 
Krzysztof P. Bzymek 
Utah State University 
Aaron Moulin 
Brandeis University 
Sabina I. Swierczek 
Utah State University 
Dagmar Ringe 
Brandeis University 
Gregory A. Petsko 
Brandeis University 
See next page for additional authors 
Follow this and additional works at: https://epublications.marquette.edu/physics_fac 
 Part of the Physics Commons 
Recommended Citation 
Bzymek, Krzysztof P.; Moulin, Aaron; Swierczek, Sabina I.; Ringe, Dagmar; Petsko, Gregory A.; Bennett, 
Brian; and Holz, Richard C., "Kinetic, Spectroscopic, and X-ray Crystallographic Characterization of the 
Functional E151H Aminopeptidase from Aeromonas proteolytica" (2005). Physics Faculty Research and 
Publications. 35. 
https://epublications.marquette.edu/physics_fac/35 
Authors 
Krzysztof P. Bzymek, Aaron Moulin, Sabina I. Swierczek, Dagmar Ringe, Gregory A. Petsko, Brian Bennett, 
and Richard C. Holz 
This article is available at e-Publications@Marquette: https://epublications.marquette.edu/physics_fac/35 
 
Marquette University 
e-Publications@Marquette 
 
Physics Faculty Research and Publications/College of Arts and Sciences 
 
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer-reviewed manuscript. The 
published version may be accessed by following the link in the citation below. 
 
Biochemistry, Vol. 44, No. 36 (1 September 2005): 12030–12040. DOI. This article is © American 
Chemical Society Publications and permission has been granted for this version to appear in e-
Publications@Marquette. American Chemical Society Publications does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from 
American Chemical Society Publications.  
 
Kinetic, Spectroscopic, and X-ray 
Crystallographic Characterization of the 
Functional E151H Aminopeptidase 
from Aeromonas proteolytica 
 
 
Krzysztof P. Bzymek 
Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 
Aaron Moulin 
Program in Biophysics and Structural Biology, Departments of Biochemistry and Chemistry and the 
Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, Massachusetts 
Sabina I. Swierczek 
Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 
Dagmar Ringe 
Program in Biophysics and Structural Biology, Departments of Biochemistry and Chemistry and the 
Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, Massachusetts 
Gregory A. Petsko 
Program in Biophysics and Structural Biology, Departments of Biochemistry and Chemistry and the 
Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, Massachusetts 
Brian Bennett 
National Biomedical EPR Center, Department of Biophysics, Medical College of Wisconsin, Milwaukee, 
Wisconsin 
Richard C. Holz 
Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 
 
SUBJECTS: 
Peptides and proteins, Monomers, Ions, Ionization 
 
Abstract 
 
Glutamate151 (E151) has been shown to be catalytically essential for the aminopeptidase from Vibrio 
proteolyticus (AAP). E151 acts as the general acid/base during the catalytic mechanism of peptide hydrolysis. 
However, a glutamate residue is not the only residue capable of functioning as a general acid/base during 
catalysis for dinuclear metallohydrolases. Recent crystallographic characterization of the d-aminopeptidase 
from Bacillus subtilis (DppA) revealed a histidine residue that resides in an identical position to E151 in AAP. 
Because the active-site ligands for DppA and AAP are identical, AAP has been used as a model enzyme to 
understand the mechanistic role of H115 in DppA. Substitution of E151 with histidine resulted in an active AAP 
enzyme exhibiting a kcat value of 2.0 min-1, which is over 2000 times slower than r AAP (4380 min-1). ITC 
experiments revealed that ZnII binds 330 and 3 times more weakly to E151H-AAP compared to r-AAP. UV−vis and 
EPR spectra of CoII-loaded E151H-AAP indicated that the first metal ion resides in a 
hexacoordinate/pentacoordinate equilibrium environment, whereas the second metal ion is six-coordinate. pH 
dependence of the kinetic parameters kcat and Km for the hydrolysis of l-leucine p-nitroanilide (l-pNA) revealed a 
change in an ionization constant in the enzyme−substrate complex from 5.3 in r-AAP to 6.4 in E151H-AAP, 
consistent with E151 in AAP being the active-site general acid/base. Proton inventory studies at pH 8.50 indicate 
the transfer of one proton in the rate-limiting step of the reaction. Moreover, the X-ray crystal structure of 
[ZnZn(E151H-AAP)] has been solved to 1.9 Å resolution, and alteration of E151 to histidine does not introduce 
any major conformational changes to the overall protein structure or the dinuclear ZnII active site. Therefore, a 
histidine residue can function as the general acid/base in hydrolysis reactions of peptides and, through analogy 
of the role of E151 in AAP, H115 in DppA likely shuttles a proton to the leaving group of the substrate. 
 
Metalloproteases that contain cocatalytic metallo-active sites are key players in numerous biological processes, 
including but not limited to tissue repair, angiogenesis, neurological processes, protein maturation and 
degradation, hormone level regulation, cell-cycle control, and bacterial antibiotic resistance (1−6). The 
importance of understanding the mechanism of action of these metalloproteases is underscored by their central 
role in disease states that include stroke, diabetes, cancer, HIV, bacterial infections, and neuropsychiatric 
disorders associated with the dysregulation of glutamatergic neurotransmission, such as schizophrenia, seizure 
disorders, and amyotrophic lateral sclerosis (ALS) (1, 2, 7−11). For example, the naturally occurring peptide 
analogue inhibitor, bestatin, was shown to significantly decrease HIV infection in males by inhibiting leucine 
aminopeptidase activity (12). Moreover, a recent study has shown that several naturally occurring 
aminopeptidase inhibitors (i.e., bestatin, leuhistin, and actinonin) inhibit matrix degradation and invasion of 
extracellular matrixes by fibrosarcoma cells (13). For these reasons, several metallopeptidases that contain 
cocatalytic active sites have become the subject of intense efforts in inhibitor design (1, 14−18). 
Different classification systems exist for metallopeptidases that include parameters such as enzymatic properties 
(catalytic function, molecular weight, pH optimum, requirement for cofactors, etc.), cellular location, and 
peptide sequence similarity (19). In the proposed catalytic mechanisms of most metallopeptidases, a glutamate 
moiety is utilized to activate a metal-coordinated water molecule and also acts as a general acid/base (20−22). 
However, in the X-ray crystal structure of the d-aminopeptidase from Bacillus subtilis (DppA),1 a member of the 
dipeptide transport protein family, an active-site histidine residue (H115) replaces the glutamate residue (E151) 
that acts as the general acid/base in the crystallographically characterized aminopeptidase from Aeromonas 
proteolytica (AAP) (22−24). Because the cocatalytic metallo-active sites of AAP and DppA contain an identical set 
of metal ligands (Figure 1), H115 of DppA was proposed to function as the general acid/base (22−24). The 
cellular role of DppA is currently unknown; it is the first product of the dpp operon expressed early in 
sporulation (25). The fact that DppA specifically acts on d-amino acids (d-Ala-D-Ala and d-Ala-Gly-Gly) suggests 
its involvement in the degradation of amino acids used in peptidoglycan synthesis (26). Enzymes in the 
biosynthetic pathway of peptidoglycan, e.g., N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE) and N-
acetyl-l-ornithine deacetylase (ArgE), are promising targets of antibacterial agents (1, 27, 28). The first 
discovered antibiotic and still most widely prescribed, penicillin, affects the cross-linking reactions of 
peptidoglycan binding to transpeptidases. In this context, understanding of the role of DppA as well as its 
mechanism of action is of great importance in the fight against the growing bacterial resistance to known 
antibiotics. 
 
Figure 1 Superposition of the active sites of APP (gray; PDB 1AMP) and DppA (gold; PDB 1HI9). 
 
AAP, while not a specific pharmaceutical target at this time, is one of the best mechanistically characterized 
metallopeptidase containing a cocatalytic metallo-active site (1, 29). Because the large majority of cocatalytic 
metallopeptidases contain active sites that are identical to that observed in AAP, the major steps of their 
catalytic mechanisms will likely be similar. Recent studies on the mechanistic role of an active-site glutamate 
residue (E151) in AAP revealed that it functions as the general acid/base (22). Therefore, we have substituted 
E151 in AAP with a histidine residue (E151H-AAP) as a model for DppA. Interestingly, E151H-AAP is active 
toward l-leucine-p-nitroanalide; therefore, the enzyme was characterized by kinetic methods. In an effort to 
gain insight into the role of H115 in the hydrolysis of d-amino acids by DppA, we have used both spectroscopic 
and crystallographic methods to examine the structure of E151H-AAP. The spectroscopic and X-ray 
crystallographic data presented herein combined with the previously reported mechanistic data for AAP (29) 
also provide additional insight into the role of E151 in the catalytic mechanism of peptide hydrolysis. 
Materials and Methods 
Mutagenesis and Enzyme Purification.  
All chemicals used in this study were purchased from commercial sources and were of the highest quality 
available. The plasmid encoding for the 51 kDa form of AAP (pVSNMC) was a generous gift from Prof. Kiyoshi 
Hayashi (30). E151H-AAP was obtained by PCR mutagenesis using the following primers:  5‘-GGC TTA TGC CGC 
TCA CGA AGT CGG CTT GCG-3‘ and 5‘-CGC AAG CCG ACT TCG TGA GCG GCA TAA GCC-3‘ (MWG Biotech, High 
Point, NC). The PCR cycling parameters, plasmid isolation, transformation into Escherichia coli BL21 Star(DE3) 
(Invitrogen, Carlsbad, CA), and growth conditions are described elsewhere (22). E151H-AAP was purified 
according to the previously published procedure with only minor modifications in the heat treatment step. 
Briefly, a starter culture was grown in sterile Luria−Bertani (LB) medium at 37 °C until an OD600 of 0.6−0.8 was 
obtained. This culture was then used to inoculate a 5 L fermentor (New Brunswick, Edison, NJ) containing sterile 
LB medium. The bacteria were grown at 37 °C with aeration until an OD600 of 1.2 was reached. At this point, the 
temperature was lowered to 25 °C followed by the addition of 1.2 g of isopropyl-β-d-thiogalactopyranoside 
(IPTG) and the bacteria were allowed to grow for 12−16 h. The cells were then harvested by centrifugation using 
a Beckman Avanti J-25 centrifuge (8000 rpm, 15 min, 4 °C). The supernatant, after centrifugation (containing LB 
broth and the protein), was saturated with ammonium sulfate. The precipitate was collected by centrifugation 
at 10 000 rpm for 45 min at 4 °C. The pellet, containing E151H-AAP, was resuspended in 30 mL of 10 mM N-
tris[hydroxymethyl]methylglycine (Tricine) buffer (pH 8.0) containing 0.1 mM ZnII. This protein solution was 
dialyzed overnight against 4 L of the same buffer. The crude supernatant, containing the protein after dialysis, 
was treated with proteinase K at 37 °C. The activity of E151H-AAP toward l-leucine-p-nitroanilide (l-pNA) was 
monitored every 5 min, and when the activity did not change after two consecutive measurements, the enzyme 
solution was heated at 50 °C, until no further changes in activity were observed. The enzyme was then 
concentrated in an Amicon stirred cell containing a YM10 membrane (Millipore Corp., Bedford, MA) to 5−10 mL, 
and NaCl was added to a final concentration of 1 M. This enzyme solution was applied to an Octyl-Sepharose 
column (3 × 30 cm) (Amersham Biosciences Corp., Piscataway, NJ) that had been pre-equilibrated with 10 mM 
Tricine buffer at pH 8.0, 1 M NaCl, and 0.1 mM ZnSO4. E151H-AAP was eluted with 10 mM Tricine buffer at pH 
8.0 containing 0.1 mM ZnSO4. The pooled fractions containing the E151H-AAP enzyme were concentrated in an 
Amicon stirred cell. To remove any additional pigment associated with the protein derived from LB broth, a 
second purification step was employed that involved applying the E151H-AAP sample to a Fast Flow Q-
Sepharose column (Amersham Biosciences Corp., Piscataway, NJ) (3 × 30 cm) pre-equilibrated with 10 mM 
Tricine buffer at pH 8.0 and 0.1 mM ZnSO4. E151H-AAP was eluted with a 0−1 M NaCl gradient. All purification 
steps were carried out at 4 °C, and the purity of each final protein sample was confirmed by sodium dodecyl 
sulfate−polyacrylamide gel electrophoresis (SDS−PAGE). 
Enzymatic Assay.  
E151H-AAP was assayed for catalytic activity with l-pNA as the substrate (31). In this assay, the hydrolysis of l-
pNA was measured spectrophotometrically by monitoring the formation of p-nitroaniline at 405 nm (ε = 10 800 
M-1 cm-1) in a cell with a 1 cm path length. All assays were performed on a Shimadzu UV-3101PC 
spectrophotometer equipped with a constant-temperature cell holder and an Isotemp 2013D water bath (Fisher 
Scientific, Pittsburgh, PA). Enzyme concentrations were determined from the absorbance at 280 nm with the 
value ε280 = 43 950 M-1 cm-1 (32). All assays were performed at 25.0 ± 0.1 °C unless stated otherwise. All 
experiments were carried out in 10 mM potassium borate buffer at pH 8.0, unless stated otherwise. 
pH Profiles.  
The enzymatic activity of E151H-AAP at pH values between 5.5 and 10.75 were measured using l-pNA as the 
substrate. The following buffers were used:  carbonate (pH 10.75−10.50), borate (pH 8.00−10.50), phosphate 
(pH 8.00−6.50), and acetate (pH 6.00−5.50). Constant ionic strength was ensured by the presence of 0.2 M KCl in 
each assay. Because of ZnII precipitation at higher pH values in phosphate buffers, the only source of ZnII in the 
pH range of 6.50−10.75 was that previously added to the enzyme during purification. It has been shown that no 
significant ZnII depletion occurs at pH values higher than 8.00 (33). To determine if ZnII depletion occurs in 
phosphate buffers between pH 6.50 and 8.00, specific activity was measured versus enzyme/buffer incubation 
time. The observed activity did not decrease upon prolonged incubation of the E151H-AAP enzyme in ZnII-free 
buffer; thus, the kinetic parameters should not be greatly affected by ZnII depletion in this pH range. At pH 6.00, 
acetate buffer was used, which contained 10 mM ZnII sulfate to prevent ZnII depletion. Additionally, at pH 5.50, 
kinetic parameters were obtained from reciprocal plots of 1/kcat versus 1/[Zn] and 1/Km versus 1/[Zn] by 
extrapolation of the kinetic parameters to saturating ZnII concentrations, as described in detail by Baker and 
Prescott (33). The kinetic parameters kcat, Km, and kcat/Km were determined using 9−10 different substrate 
concentrations in the range of 0.2−10.0 Km at each pH value. Kinetic parameters and pH dependence fits were 
obtained using Igor Pro (Wavemetrix, Inc., Lake Oswego, OR) and SigmaPlot (SPSS, Inc., Chicago, IL) by fitting the 
experimental data to the appropriate equations. 
Solvent Isotope Effect.  
All buffers were prepared in 99.9% [2H] H2O from a freshly opened bottle (Aldrich). Buffers with the desired 
atom fraction of deuterium were prepared by combining appropriate volumes of buffers made in H2O and D2O. 
The pH of each buffer used was adjusted using NaOD or DCl (both 99%+ deuterium content; Acros Organics, 
Geel, Belgium) and corrected for deuteration by adding 0.4 to the nominal pH reading of the pH meter. The 
buffer (10 mM potassium borate at pH 8.50) was prepared from the anhydrous salt and did not contain any 
ZnII salts as zinc hydroxide/borate precipitates under these conditions. 
Apoenzyme Preparation.  
Purified and concentrated E151H-AAP (approximately 20 mg/mL) was incubated with 10−15 mM disodium EDTA 
at 4 °C until no activity was observed (usually 1−3 days). To remove EDTA, the protein was dialyzed extensively 
against 100 times the volume of chelexed 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
buffer at pH 7.5. The metal content was determined by inductively coupled plasma−atomic emission 
spectroscopy (ICP−AES) (Department of Agriculture, USU); zinc content in the protein was found to be less than 
1%. All plasticware used for dialysis and the dialysis tubing were presoaked in a disodium-EDTA/bicarbonate 
solution to remove traces of metals and then extensively washed with Nanopure water (NANOpure Ultrapure 
Water System, Barnstead/Thermolyne, IA) and chelexed HEPES buffer. 
Isothermal Titration Calorimetry (ITC). 
 ITC measurements were carried out on a MicroCal OMEGA ultrasensitive titration calorimeter (MicroCal, Inc., 
Northampton, MA). The titrant (CoCl2, 99.999%, and ZnCl2, 99.999%, Acros Organics and Aldrich, respectively) 
and sample solution of apoprotein were prepared in chelexed 50 mM HEPES buffer at pH 7.5 and degassed prior 
to the experiment. The binding constant of Tricine to apo-E151H-AAP was also measured using a Tricine solution 
(50 mM) prepared in chelexed HEPES buffer. The pH of the resulting solution was adjusted to 7.5, and the 
binding constant for ZnII-reconstituted E151H-AAP was determined using identical conditions to the metal-
binding experiments. In a typical experiment, the enzyme (70 μM) was placed in the calorimeter cell and stirred 
at 200 rpm to ensure rapid mixing. Typically, 4−10 μL of the titrant was delivered over 7.6 s with 7-min intervals 
between injections to allow for complete equilibration. Each titration was continued until 3−6 equiv of the 
titrant had been added to ensure that no complexes formed in excess titrant. All titrant solutions for the 
determination of metal-binding constants were prepared in the same buffer as the protein to avoid any heat of 
dilution or metal complexation. A background titration, consisting of the identical titrant solution but only the 
buffer solution in the sample cell, was subtracted from each experimental titration to account for the heat of 
dilution. The data were analyzed using a Windows-based Origin software package supplied by MicroCal. 
Spectroscopic Measurements.  
Electronic absorption spectra were recorded on a Shimadzu UV-3101PC spectrophotometer, and all solutions 
were degassed prior to performing an experiment. Apo-E151H-AAP (typically 0.3−1.2 mM) was incubated with 
CoII (CoCl2, ≥99.999%, Acros Organics, Geel, Belgium) for ∼10 min at 25 °C before a spectrum was recorded. 
Apoprotein absorbance was subtracted from spectra obtained with CoII using IgorPro (Wavemetrix, Inc., Lake 
Oswego, OR). Electron paramagnetic resonance (EPR) spectra were recorded using a Bruker ESP-300E 
instrument with an ER 4116 DM TE102/TE012 dual-mode X-band cavity and an Oxford Instruments ESR-900 helium 
flow cryostat. All spectra were recorded at a modulation frequency of 100 kHz and a modulation amplitude of 
12.6 G (1.26 mT). Protein concentrations used for the experiment were approximately 1 mM. Exact microwave 
frequencies and temperatures for individual spectra are provided in the figure captions. Computer simulations 
of EPR spectra were carried out using Xsophe version 1.1.2 (Bruker Biospin GmbH, Rheinstetten, Germany) (34). 
Parameters were fit to the spin Hamiltonian 
𝐻 =  𝛽𝑔𝐻𝑆 +  𝑆𝐷𝑆 +  𝑆𝐴𝐼 
(1) 
Under this formalism, D > 0 corresponds to a MS = |±1/2〉 ground state and D < 0 corresponds to an MS = |±3/2
〉 ground state. 
Crystallization. 
 E151H-AAP was crystallized using the crystallization conditions reported for the native enzyme (35). Briefly, 
purified E151H-AAP (15 mg/mL) in 10 mM HEPES at pH 7.2, 10 mM KSCN, and 0.4 M NaCl was crystallized by 
vapor diffusion using 100 mM HEPES at pH 7.2, 100 mM KSCN, and 4.5 M NaCl as the precipitating solution. 
E151H-AAP crystals with dimensions 0.5 × 0.5 × 0.3 mm were obtained in 2−3 days and had identical 
morphology to wild-type (WT) crystals. The crystals belong to space group P6122 with the following until cell 
dimensions:  a = b = 109.6 Å, c = 91.3 Å, α = β = 90°, and γ = 120°. There is one monomer per asymmetric unit. 
Data Collection and Processing. Diffraction data were collected at room temperature (25 K) on an in-house 
source consisting of a Rigaku RU-300 rotating anode (copper anode) and a R-axis IV detector. Crystals were 
mounted into quartz capillaries directly from the drop. Molding putty was used to stabilize the capillary and 
mount it to the goniometer head. One crystal was used for the entire data collection period. Exposure times 
were 15 min, and the oscillation range was 0.75°. The beam size was 0.1 mm, and the crystal−detector distance 
was 110 mm. The diffraction data were integrated and scaled using Denzo and Scalepack (36). Data Collection 
and refinement statistics are provided in Table 1. It should be noted that here a resolution cutoff at I/σ = 2.8 was 
chosen. This is generally not practiced, and a resolution cutoff with I/σ = 2.0 is preferred. However, because of 
beam incoherency and limitation with the in-house detector diffraction fell off sharply at a resolution higher 
than 1.9 Å, falling to I/σ = 1.2 with an increase in Rmerge to values greater than 80%. Hence, the choice was made 
to include only data at a resolution of 1.90 Å. 
Table 1:  Data Collection and Refinement Statistics 
crystal data   
space group P6122 
unit cell parameters (Å) a = 106.9 
  b = 106.9 
  c = 91.3 
data processing   
number reflections, observed 457 444 
number reflections, unique 27 824 
cuttoff (I/σ) 2.8 
Rmergea (overall) (%) 10.5 
completeness, overall (%) 98.4 
highest resolution shell (Å) 1.97−1.90 
Rmergea (outer shell) (%) 56.6 
completeness, outer shell (%) 99.3 
overall I/σ 20.6 
model refinement   
resolution range (Å) 50.0−1.9 
cuttoff (F/σF) 0 
R factorb (%) 18.0 
Rfree (for 2624 reflections; %) 20.5 
number of reflections 23 654 
number of protein atoms 2212 
number of zinc ions 2 
number of water molecules 151 
B factor model individual 
rmsd from ideality   
bond lengths (Å) 0.004 
bond angles (deg) 1.19 
improper angles (deg) 0.76 
dihedral angles (deg) 22.8 
residues in most favored positionsc (%) 84.0 
residues in disallowed regions (%) 0.0 
a Rmerge = ∑|Iobs − Iavg|/∑Iavg|.b R factor = ∑|Fobs − Fcalc|/∑|Fobs|.c As determined by PROCHECK. 
 
Structure Solution and Refinement.  
Phases were derived from a previously solved structure (PDB accession code 1AMP) in which the native 
glutamate residue in position 151 was replaced by an alanine residue. In this process, water molecules were 
omitted from the original coordinate file. All refinement procedures were carried out using the software 
package CNS (37). A Rfree data set was made prior to any refinement using 10% of the total reflections. The initial 
model was subjected to a rigid-body refinement using all reflections in the 50.0−3.5 Å resolution range. After 
one round of rigid-body refinement with 20 cycles of refinement, the R factor and Rfree were 32.5 and 33.5%, 
respectively. Because of the marked length change in the c axis (greater than 6 Å), a second round of rigid-body 
refinement was carried out to place the monomer better within the density. After this second round of rigid-
body refinement, the R factor and Rfree were 24.4 and 25.3%, respectively. After the second round of rigid-body 
refinement, one round each of simulated annealing, coordinate energy minimization and B-factor refinement 
were carried out. The R factor and Rfree at this point were 23.0 and 25.3%, respectively, for E151H-AAP (38). 
Electron-density maps with amplitudes 2Fobs− Fcalc and Fobs− Fcalc were then calculated and showed clear electron 
density in the active site for a histidine residue at position 151 (rather than the alanine residue contained in the 
starting model). At this point, a histidine residue was modeled into the density at position 151 in place of the 
alanine using O (40). Subsequent manual manipulations of all atomic models were performed in O. The model at 
this point was subjected to positional refinement and individual B-factor refinement. Electron-density maps 
were calculated, and manual repositioning of residues was performed. Water molecules were added to the 
model using the WATERPICK protocol in the CNS program. After the first round of water picking, the R factor 
and Rfree were 20.8 and 23.5%, respectively. A sodium ion was added at this point in the refinement; it was 
judged to be a sodium ion because of an obvious octahedral arrangement of waters and protein-derived 
hydroxyl groups. Further rounds of positional refinement as well as individual B-factor refinement protocols 
were performed always followed by map calculation and manual repositioning of residues. After these 
refinements and an additional round of water picking, the final structure had reached a R factor of 18.0% and 
a Rfree of 20.5%. 
Results 
Kinetic Properties of E151H-AAP.  
The kinetic properties of E151H-AAP were initially determined in 10 mM Tricine buffer at pH 8.0 containing 0.1 
mM ZnSO4. A Km value of 49.2 μM toward l-pNA was determined, which is ∼5 times higher than that observed 
for r AAP (20). Because we suspected the increased Km to be the result of Tricine inhibition, an inorganic borate 
buffer was used for further experiments. In 10 mM borate at pH 8.50 containing 0.2 M KCl, the Km values for 
recombinant leucine aminopeptidase (rAAP), E151D-AAP, and E151H-AAP were very similar (16.4, 22.9, and 25.5 
μM, respectively). The turnover number, kcat, was 2.0 min-1, nearly identical to that of E151D-AAP (2.4 min-1) and 
2200 times lower than that of AAP (kcat = 4380 min-1) (22). 
ITC.  
ITC experiments were conducted on apo-E151H-AAP to determine the metal dissociation constants (Kd) (parts A 
and B of Figure 2). The heat of reaction, measured during the experiment, is converted into association 
constants (Ka) using the Gibbs free-energy relationship 
∆𝐺° =  −𝑅𝑇 ln(𝐾a)  =  ∆𝐻° −  𝑇∆𝑆° 
(2) 
where R = 1.9872 cal mol-1 K-1. The relationship between Ka and Kd is defined as 
𝐾d  =  1/𝐾a 
(3) 
For each measurement, the background heat of dilution was subtracted and Ka values were obtained by fitting 
these data via an iterative process using the Origin software package. The equilibrium binding constant, the 
enzyme−metal stoichiometry (n), and the change in enthalpy (ΔH) were allowed to vary during the fitting 
process (Table 2). The best fit was obtained using a model for two noninteracting sites (n = 2) (bottom panel in 
parts A and B of Figure 2). The Kd values obtained for ZnII binding to E151H-AAP were 1.0 and 940 μM, for the 
first and second metal-binding events, respectively, which are 330 and 3 times weaker than WT-AAP. On the 
other hand, the Kd values obtained for CoII binding to E151H-AAP were ∼120- and ∼5000-fold weaker for the 
first and second binding sites, respectively, versus r AAP. In addition, ITC experiments revealed that two Tricine 
molecules weakly interact with ZnII-loaded E151H-AAP with Kd values of 5.2 and 26.9 mM, respectively. These 
values are similar to those observed for Tricine binding by ZnII-loaded r AAP (Kd1 = 4.6 mM and Kd2 = 13.9 mM) 
(24). 
 
Figure 2 Isothermal titration data for the titration of apo-E151H-AAP with ZnII (A) and CoII (B) in 50 mM HEPES 
buffer at pH 7.5 and 25 °C. 
 
Table 2:  Metal-Binding Constants and Thermodynamic Parameters for CoII and ZnII Binding to Apo-E151H-AAP 
  n K1, K2 (M-1) ΔH1, ΔH2 (kcal mol-1) TΔS1, TΔS2 (kcal mol-1) ΔG1, ΔG2 (kcal mol-1) 
[ZnZn(E151H)] 1.08 9.62 × 105 2.01 10.17 −8.16 
  1.10 1.06 × 103 3.94 8.07 −4.13 
[CoCo(E151H)] 1.00 8.89 × 104 2.53 9.28 −6.75 
  1.15 575 8.39 12.15 −3.76 
[ZnZn(rAAP)] 1.21 3.19 × 108 1.36 12.95 −11.59 
  1.05 3.93 × 103 5.23 10.14 −4.91 
[CoCo(rAAP)] 0.97 1.06 × 107 0.21 9.71 −9.50 
  0.90 2.77 × 106 10.03 18.45 −8.42 
 
pH Dependence.  
To further characterize the role of H151 in the catalytic mechanism of peptide hydrolysis, the kinetic 
parameters Km, kcat, and kcat/Km were recorded as a function of pH (Figure 3). The obtained kinetic data were 
plotted as log(parameter) versus pH and fit to eq 4 
parameter =  𝑐/(1 + [H+]/𝐾1  +  𝐾2/[H
+]) 
(4) 
where parameter is kcat or kcat/Km and K1 and K2 are the respective ionization constants, while [H+] is the 
hydrogen ion concentration in solution. The observed changes in kcat are small over the pH range of 7.5−9.5, but 
a sharp drop is observed below pH 7.5 with a single inflection at 6.4. A smaller drop is observed on the basic 
limb, with an apparent ionization at 11.2 (Figure 3B). The plot of log(kcat/Km) versus pH reveals one inflection in 
the acidic range, at 7.6, similar to the ionization constant of the substrate (7.7) (33) and one in the basic range at 
10.8, which on the basis of previous studies was assigned to Y225 (Figure 3C) (22). The solid line in log Km versus 
pH (Figure 3A) was obtained by subtracting the theoretical plots of log kcat/Km from log kcat obtained using eq 4; 
thus, the inflection points reflect groups with ionizations at 6.4, 7.6, 10.8, and 11.2. 
 
Figure 3 pH dependence of the observed kinetic parameters for the hydrolysis of l-pNA by E151H-AAP. (A) pH 
dependence of Km, obtained by subtraction of log(kcat/Km) from log kcat ( ); pKe1 = 6.5, pKHS = 7.6, pKe2 = 10.9, 
and pKe3 = 11.2. (B) pH dependence of log kcat, fit to the experimental data using eq 4 ( ); pKES1 = 6.4 and pKES2 = 
11.2. (C) pH dependence of log(kcat/Km), fit to the experimental data using eq 4 ( ); pKHS = 7.6 and pKe2 = 10.9. 
Fits were obtained using Igor Pro (Wavemetrix, Inc., Lake Oswego, OR) and SigmaPlot (SPSS, Inc., Chicago, IL). 
Error bars are smaller than the symbols used. 
 
To determine the identity of the ionizing group exhibiting a pKa of 6.4, the temperature dependence of kcat was 
determined at saturating concentrations of substrate (4.5 mM) at several pH values between 5.5 and 8.0. These 
data were fit to eq 5, which provided three ionization constants, one for each temperature. A plot of ionization 
constants versus inverse absolute temperature yields a slope equal to 
slope =  ∆𝐻ion/2.303𝑅 
(5) 
where R is the gas constant (Figure 4). The enthalpy of ionization calculated from these data is 3.3 ± 0.3 
kcal/mol, more than twice the value expected for a carboxylate group (∼1.5 kcal/mol) (39) but somewhat lower 
than typical values for histidine residues (6.9−7.5 kcal/mol). 
 
Figure 4 Temperature dependence of the ionization constant of the enzyme−substrate complex (pKES1). 
Calculated ΔHion is 3.3 ± 0.3 kcal/mol. 
 
Solvent Isotope Effect.  
Solvent isotope effect experiments were carried out at pH 8.50. Proton inventories were obtained by fitting the 
experimental data to equations derived from the Gross−Butler equation as previously described (22). The best 
fit obtained for E151H-AAP indicated that only one proton is transferred in the rate-limiting step of the reaction 
at pH 8.50 (Figure 5A). The fit yielded a fractionation factor of 0.42, similar to the fractionation factor found at 
pH 10.50 for WT-AAP (0.37) (22), which was proposed to result from the transfer of a proton to the leaving 
group of the substrate. The overall kinetic isotope effect is 2.42, which is slightly smaller than that observed for 
r-AAP at pH 8.00 (2.73) and 20% smaller than that observed for r-AAP or E151D-AAP at pH 10.50 (2.95 and 2.99) 
(22). No changes in Km were observed in D2O buffers at a pH/pD of 8.50 (Figure 5B), and a nonunitary value of 
the solvent isotope effect clearly show that substrate binding is not rate-limiting (40). 
 
Figure 5 (A) Proton inventory of l-pNA cleavage by E151H-AAP at pH/pD 8.50. Rate ratio is defined as kn/kcat,HOH, 
where n is the atom fraction of deuterium. The fractionation factor was obtained by fitting the experimental 
data to the Gross−Buttler equation (48, 56) and found to be φT = 0.42. (B) Dependence of Km on the atom 
fraction of deuterium at pH/pD 8.50. 
 
Spectroscopic Studies.  
Electronic absorption spectra were recorded for [Co_(E151H-AAP)], [CoCo(E151H-AAP)], and [ZnCo(E151H-
AAP)], and the absorbance of the apoprotein was subtracted (Figure 6). Electronic absorption spectra of 
[Co_(E151H-AAP)] revealed significant changes in both the shape and energy of the observed transitions, with 
the largest change being observed for the first metal-binding site. Although a transition at approximately 525 
nm observed for [Co_(E151H-AAP)] is typical for WT AAP, a broad shoulder was also observed with a λmax of 546 
nm. A second, well-defined maximum was observed at 586 nm, with another shoulder at ∼625 nm. The addition 
of a second equivalent of CoII did not change the shape of the observed spectrum but resulted in an increase in 
the molar absorptivity by 21 M-1 cm-1 at 522 nm. The addition of ZnII to apo-E151H did not result in any change in 
the molar absorptivity (ε), but the addition of CoII to [Zn_(E151H-AAP)] produced a spectrum very similar to 
[ZnCo(AAP)] with a molar absorptivity of 19 M-1 cm-1 at 525 nm. 
 
Figure 6 UV−vis absorption spectra of E151H-AAP titrated with CoII (from bottom to top:  [Zn_(E151H-AAP)], 
solid line; [ZnCo(E151H-AAP)], dashed line; [Co_(E151H-AAP)], solid line; and [CoCo(E151H-AAP)], dashed line). 
 
EPR spectra of the CoII-substituted forms of E151H-AAP were also recorded, and each exhibited an axial MS = 
|±1/2〉 signal, although simulation indicates some rhombicity (E/D = 0.11), consistent with moderate spin−orbit 
coupling (gx,y = 2.42 and gz = 2.45) (Figure 7). The strong similarity of the observed EPR spectra of [Co_(E151H-
AAP)], [ZnCo(E151H-AAP)], and [CoCo(E151H-AAP)] suggests that these samples both contain appreciable 
amounts of a common species. A minor species in the EPR spectrum of [Co_(E151H-AAP)] exhibits hyperfine 
structure (Aeff = 0.011 cm-1 = 103 G), for which only the low-field g value can be resolved with geff for the visible 
feature around 8.05. 
 
Figure 7 EPR spectra of CoII-substituted E151H-AAP. (A) EPR spectrum of [Co_(E151H-AAP)] recorded at 10 K and 
0.2 mW microwave power. (B) simulation of spectrum A with g(x,y,z) values of 2.42, 2.42, and 2.45 (S = 3/2; MS = 
|±1/2〉). (C) EPR spectrum of [CoCo(E151H-AAP)] recorded at 10 K and 0.2 mW microwave power. (D) EPR 
spectrum of [ZnCo(E151H-AAP)] recorded at 10 K and 0.2 mW microwave power. 
 
X-ray Structure of E151H-AAP.  
The X-ray crystal structure of [ZnZn(E151H-AAP)] was solved to 1.9 Å resolution and is shown in Figure 8. 
Alteration of E151 to histidine does not introduce major conformational changes to the overall protein 
structure. The structure of [ZnZn(AAP)] and [ZnZn(E151H-AAP)] agree with a root-mean-square deviation (rmsd) 
of 0.042 Å for the 291 structurally equivalent Cα atoms. The amino acid residues ligated to the dizinc(II) cluster 
in E151H-AAP are identical to those in the native structure with only minor perturbations to the bond lengths 
(Table 3). Zn1 of [ZnZn(E151H-AAP)] exhibits a distorted tetrahedral coordination geometry or a distorted 
trigonal bipyramidal geometry, with the Nε nitrogen of H256 and the bridging water/hydroxide oxygen atom 
making up the axial positions, if both oxygen atoms if E152 are counted as ligands. Similarly, Zn2 resides in a 
distorted tetrahedral coordination geometry or a distorted trigonal bipyramidal geometry, with the Nε nitrogen 
of H97 and the bridging water/hydroxide oxygen making up the axial positions, if both oxygen atoms of D179 are 
counted as ligands. E152 is coordinated in an asymmetric bidentate fashion to Zn1, with the additional oxygen 
atom providing a potential fifth ligand at a distance of 2.6 Å. Similarly, D179 is coordinated to Zn2 in an 
asymmetric bidentate fashion, with the second oxygen atom residing 2.6 Å from the metal center providing a 
potential fifth ligand. The M−M distance for the E151H-AAP is 3.4 Å with water/hydroxide oxygen atom 
distances of 2.0 and 2.1 Å from Zn1 and Zn2, respectively. A hydrogen bond exist between H151 and the 
bridging water/hydroxide with a distance of 3.1 Å (Figure 9). Another potentially important hydrogen-bonding 
interaction is also observed between an oxygen atom of D99 and the Nδ nitrogen of H97 (2.9 Å), forming an Asp-
His-Zn triad (41). 
 
Figure 8 Stereoview of the E151H-AAP active site showing Zn1 and Zn2, along with all of the active-site ligands 
and the bridging water molecule. There is no evidence for bound amino acids or peptides. 
 
 
Figure 9 Overlay of the active sites of E151H-AAP and WT AAP showing only the Zn1 and Zn2 ions along with 
E151 (WT) and H151 and the bridging water molecule. The remaining zinc ligands have been removed for clarity. 
Copper-colored zincs belong to the WT, and the silver-colored zincs belong to E151H. 
 
Table 3:  Selected Bond Lengths (Å) for WT and E151H AAP 
  zinc−ligand distance (Å)a  
  WT E151H 
Zn1−Zn2 3.5 3.4 
Zn1−D117 O2 2.1 2.0 
E152 O1 2.0 2.0 
E152 O2 2.4 2.6 
H256 N2 2.3 2.1 
H2O 2.3 2.0 
Zn2−D117 O1 2.0 1.9 
D179 O1 2.1 2.1 
D179 O2 2.3 2.6 
H97 N2 2.3 2.1 
H2O 2.3 2.1 
E151 O1 3.4   
H151 N   3.1 
a The relative error in distance values is ∼0.2 Å. 
 
Discussion 
Recently, the X-ray crystal structure of DppA was determined at 2.4 Å resolution and revealed that DppA 
crystallizes as a decamer (23). The C-terminal domains are involved in electrostatic and hydrophobic interactions 
between the two pentamers in the decamer, whereas the N-terminal domain is responsible for intersubunit 
contacts between the pentamers (23). A cocatalytic ZnII-binding site resides in the N-terminal domain of each 
monomer, which places them at the center of a 20 Å channel that forms a 50 Å cavity. Similar to AAP, the active 
site consists of a (μ-aquo)(μ-carboxylato)dizinc(II) core and a Zn−Zn distance of 3.1 Å. The two ZnII ions are 
coordinated by E10, H60, E133, and H104, with D8 serving as the bridging ligand. Surprisingly, no glutamic acid 
residue(s) are near the cocatalytic ZnII active site that can function as the general acid/base during catalysis. 
However, H115 forms a hydrogen bond to the bridging water molecule, suggesting that, in DppA, a histidine 
residue takes the place of the glutamic acid residues observed in the aminopeptidases AAP and Streptomyces 
griseus (SAP) as well as carboxypeptidase A (CPA) and carboxypeptidase G2 from Pseudomonas sp. strain RS-16 
(CPG2) (1, 29, 35, 43, 44). Unfortunately, no data is available that addresses the role of H115 in the catalytic 
process of d-amino acid cleavage by DppA. Because the active sites of DppA and AAP are superimposable, 
glutamate (E151), which functions as the general acid/base during catalytic turnover in AAP (22), was altered to 
a His residue to investigate if a His can function in this capacity in AAP and to serve as a model system for DppA. 
Kinetic studies on E151H-AAP revealed a drastic change in catalytic activity. A comparison of the kcat values of 
E151H-AAP (2.0 min-1) with E151D-AAP (2.4 min-1), E151A-AAP (0 min-1), and r-AAP (4380 min-1), under the same 
conditions (10 mM borate at pH 8.50 and 0.2 M KCl), reveals that E151 is critical for the catalytic activity of AAP 
(22). Because the activity level of E151H-AAP is ∼2000 times lower than that observed for r-AAP, the metal-
binding properties of the E151H altered AAP were investigated via ITC. ITC measurements of ZnII binding to 
E151H-AAP provided Kd values of 1.0 and 940 μM, for the first and second metal-binding sites, respectively. 
These values are 330 and 3 times weaker than that observed for WT-AAP. Therefore, H151 perturbs the first 
metal-binding site more than that of the second ZnII-binding site, but the E151H-AAP enzyme can still bind two 
divalent metal ions. Interestingly, the Gibbs free energy does not change significantly upon substitution of E151 
by histidine and is similar to that observed for r-AAP, E151D-AAP, and E151A-AAP (53). Similarly, the entropic 
factor (TΔS) remains approximately the same for the first metal-binding event despite a drastic decrease in Kd. 
However, TΔS increases significantly for the second metal-binding event in the order:  E151D < E151H < r-AAP, 
suggesting a decrease of order around the second metal-binding site. 
At pH 8.50, a histidine residue is a better proton shuttle than glutamate because the pKa of the imidazole ring is 
closer to pH 8.50 than that of a glutamate, yet E151H-AAP is significantly less active than r-AAP. To address this 
issue, the pH dependence of the kinetic parameters of [ZnZn(E151H-AAP)] were examined and revealed a 
significant change compared to that observed for rAAP and E151D-AAP (22). Inspection of a plot of log Km versus 
pH revealed a small change in the basic limb of the plot (pKa = 10.9), suggesting that a tyrosine residue interacts 
with the substrate (33). The small increase in Km upon substitution of E151 with histidine supports this 
conclusion and at the same time excludes the possibility of a large rearrangement of the active site. Curvature in 
the acidic limb provides two inflection points at 6.4 and 7.6. On the basis of previous studies, the latter is 
assigned to the N-terminal amine of the substrate (l-pNA) (33). The ionizing group with a pKa of 6.4 is not 
observed in pH plots of rAAP and E151D-AAP, suggesting that this ionization is the result of H151. To further 
determine the identity of this ionizing group, the temperature dependence of kcat was determined. The enthalpy 
of ionization was found to be 3.3 ± 0.3 kcal/mol, more than twice the value expected for a carboxylate group 
(∼1.5 kcal/mol) (39) but approximately half the value typical for histidine residues (6.9−7.5 kcal/mol). This 
difference may be the result of hydrogen-bond formation between H151 and the bridging water molecule. 
Ionizations derived from plots of log(kcat/Km) versus pH correspond to ionizations of the free enzyme and free 
substrate (33, 39). A fit of the experimental data to a simple, two-site model, provided two ionization constants:  
one in the acidic limb at 7.6 that is assigned to the ionization constant of the amino group of the substrate and 
one in the basic range at 10.9. Interestingly, the most profound difference between the observed pH 
dependence of E151H-AAP versus rAAP appears in plots of log kcat versus pH, which provided pKa values of 6.4 
and 11.2. The first can be assigned to H151 based on the temperature dependence of the ionization constant of 
this group as well as a comparison to pH profiles of rAAP and E151D-AAP (22). These data strongly support the 
assignment of the ionizing group observed in the pH profiles of log kcat for rAAP at pH 5.3 to E151 (22). The 
second ionization constant at 11.2, although outside of the pH range used for pH-dependence experiments and 
thus bearing a large error, was easily reproducible and not present in rAAP or E151D-AAP pH profiles; thus, it is 
likely for the ionization of the imidazole ring to form a histidinate. The observed pKa of 11.2 is not significantly 
different from the pKa of 13−14, observed for imidazole (45). However, on the basis of X-ray crystallographic 
data and chemical modification studies, this pKa was previously assigned to Y225 (33, 46). If this pKa is due to 
Y225, its catalytic role in E151H-AAP may be the donation of a proton to the −NH- of the leaving group, because 
tyrosine is a stronger acid than amine (9.8−10.5 versus ∼15). However, Y225 is rather far from the dinuclear 
metal center (∼8 Å) in WT-AAP and thus not a probable proton donor to the leaving group (35). To address this 
proton-transfer process further, proton inventory studies at pH 8.50 were conducted. These data are consistent 
with one proton being transferred in the rate-limiting step of the reaction at pH 8.5. On the basis of previous 
studies, this single proton transfer can be assigned to the proton of the general acid (H151) to the leaving group 
of the substrate (47, 48). 
Electronic absorption spectra of the catalytically competent [Co_(E151H-AAP)], [CoCo(E151H-AAP)], and 
[ZnCo(E151H-AAP)] enzymes were recorded to gain structural information about the E151H altered AAP 
enzyme. For a high-spin CoII ion residing in a pentacoordinate field, five transitions from the ground 
state 4A‘2 level to (4A‘ ‘2, 4A‘ ‘2), 4E‘ ‘, 4E‘, 4A‘2(P), and 4E‘ ‘(P) levels are predicted (49). Although the molar 
absorptivity (ε) of [Co_(E151H-AAP)] is comparable to [Co_(AAP)] (55 versus 56 M-1 cm-1) suggesting a 
pentacoordinate metal ion for the first metal-binding site, the shape and number of electronic transitions 
suggest a significant change in geometry (35, 50, 51). Addition of a second CoII ion to [Co_(E151H-AAP)] results 
in a small increase in ε (∼21 M-1 cm-1) almost identical to the molar absorptivity increase observed for 
[ZnCo(E151H-AAP)] (ε value of 19 M-1 cm-1). The relatively small molar absorptivity increase coupled with the 
lack of multiple resolved transitions strongly suggests that the second divalent metal-binding site is octahedral, 
identical to that proposed for WT-AAP (52). 
EPR spectra of the CoII-substituted forms of E151H-AAP including [ZnCo(E151H)] are intriguing because they are 
almost indistinguishable and are dominated by a MS = |±1/2〉 signal with low rhombicity. The very close 
similarity between the EPR spectra of [ZnCo(E151H-AAP)], [Co_(E151H-AAP)], and [CoCo(E151H-AAP)] is in 
marked contrast to the differences between the spectra of [Co_(AAP)], [ZnCo(AAP)], and [CoCo(AAP)], 
respectively, and between those of the CoII-substituted forms of the E151 variants of AAP ([Co_(E151A-AAP)] 
and [CoCo(E151A-AAP)]) (53). These comparisons suggest that either the binding mode of E151H differs from 
that of WT AAP or else the structures of the metal centers, particularly the first metal-binding sites, differ. The X-
ray crystal structure of the WT enzyme indicates a distorted tetrahedral of trigonal bipyramidal for Zn1 and a 
trigonal bipyramidal geometry for Zn2 (35), whereas electronic absorption and EPR spectroscopies of the CoII-
substituted forms are indicative of a five-coordinate Co1 center and an octahedral Co2 site. The crystal structure 
of E151H-AAP suggests that both Zn1 and Zn2 reside in trigonal bipyramidal coordination geometries. 
Interestingly, the EPR and electronic absorption data are most compatible with hexacoordinate Co1 and 
Co2 centers. In fact, examination of another AAP variant, E151D-AAP, also suggested two hexacoordinate 
CoII ions (53). More detailed examination of both the optical and EPR spectra actually suggests a slightly more 
complex situation, in which Co1 is in equilibrium between five and six coordinate. The optical absorption 
spectrum of [Co_(E151A-AAP)] is more intense than that of [ZnCo(E151H-AAP)] by a factor of ∼2.5 and contains 
a structure unexpected for octahedral CoII. Careful examination of the EPR spectrum of [Co_(E151A-AAP)] shows 
a hyperfine pattern that is significantly diminished in the spectra of [CoCo(E151A-AAP)] and barely discernible in 
that of [ZnCo(E151A-AAP)]. A full-spin Hamiltonian parameter set cannot be obtained for this signal but it is 
clear that (i) the strains are very low, suggesting a more constrained geometry and/or fewer solvent ligands, and 
(ii) the rhombic distortion of the axial zero-field splitting is very high. The most likely interpretation of these data 
is the presence of a five-coordinate species of Co1, analogous to Zn1, that is in equilibrium with a predominant 
six-coordinate species that is formed upon acquisition of a solvent-derived sixth ligand. 
Spectroscopic studies suggest that the active site of E151H-AAP still binds two divalent metal ions but that a 
significant conformational change occurs for site one. However, no detailed information regarding any 
interaction of H151 within the active site is obtainable from spectroscopic data alone. Therefore, the X-ray 
crystal structure of E151H-AAP was determined to 1.9 Å resolution (Figure 8). The E151H-AAP structure provides 
structural information that can be used as a model for DppA. Like all of the structures reported for AAP and its 
inhibited complexes, a well-defined hydrophobic pocket is adjacent to the dinuclear ZnII active site (35, 54). This 
hydrophobic pocket has been shown to be the initial substrate recognition and binding point on the enzyme that 
constitutes the first step in the catalytic mechanism (55). Substitution of E151 with a histidine residue does not 
alter the ZnII−ZnII distance and does not change the coordination number of either ZnII, consistent with the 
electronic absorption and EPR data. No active-site ligands are displaced upon substitution of E151 with a 
histidine residue. A bridging water molecule is present between the two ZnII ions, and H151 forms a hydrogen 
bond with this water molecule, similar to that observed for WT-AAP (Figure 9). H151 presumably can abstract a 
proton from this water molecule and, on the basis of isotope studies, transfer that proton to the newly formed 
N-terminal amine group in the transition state, similar to one of the roles of E151 in WT-AAP (22). 
In conclusion, characterization of E151H-AAP has provided insight into the ability of a histidine residue to 
function as the general acid/base in hydrolysis reactions of peptides. Although this amino acid has a higher 
ionization constant than a glutamate, it is still capable of deprotonating the bridging water molecule (pKa ∼ 7), 
thus creating an active-site nucleophile. Through analogy of the role of E151 in AAP, H115 in DppA likely shuttles 
a proton to the leaving group of the substrate. In addition, pH-dependence studies on E151H-AAP allowed the 
assignment of an ionizable group in the enzyme−substrate complex of AAP to E151. Significant changes around 
the geometry and binding of the first metal ion in the active site, combined with kinetic experiments, point to 
Zn1, which is coordinated to H256, as the catalytically relevant metal ion. 
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